For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Alzheimer's Disease can seem like a tragic inevitability for those who have rare genetic forms of the disease. The ...

Alzheimer’s disease can cause a person to act in different or unpredictable ways. Some individuals with Alzheimer’s become ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

New research suggests that blood tests used to diagnose Alzheimer's disease have racial disparities. Here's what's going on ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Alzheimer's disease is the most common form of dementia in the UK, affecting one in 14 people over the age of 65 and one in ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.